Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Obinutuzumab in Combination With Chemotherapy in Participants With CD20+ B-Cell Follicular Non-Hodgkin's Lymphoma (GAUDI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00825149
Recruitment Status : Completed
First Posted : January 19, 2009
Last Update Posted : November 4, 2016
Sponsor:
Information provided by (Responsible Party):
Hoffmann-La Roche